| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks | Director
1 company
Funtleyder Leslie D. is a Chief Financial Officer at Applied Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 26 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | APLT Applied Therapeutics, Inc. | See Remarks | Sell | 14,502 | $0.44 | $6,380.88 | -3.6% | -26.2% | - | |
| Feb 6, 2025 | APLT Applied Therapeutics, Inc. | See Remarks | Sell | 22,950 | $0.61 | $13,999.50 | -5.4% | -31.1% | -83.1% | |
| Aug 22, 2024 | APLT Applied Therapeutics, Inc. | Chief Financial Officer | Sell | 13,530 | $5.83 | $78,879.90 | -4.6% | +68.4% | -90.9% | |
| Jun 6, 2024 | APLT Applied Therapeutics, Inc. | Chief Financial Officer | Sell | 16,980 | $4.32 | $73,353.60 | -5.5% | +26.7% | -91.8% | |
| Mar 14, 2024 | APLT Applied Therapeutics, Inc. | Chief Financial Officer | Sell | 28,727 | $5.39 | $154,838.53 | -8.5% | -9.5% | -91.2% | |
| Oct 2, 2020 | APLT Applied Therapeutics, Inc. | Director | Sale+OE | 30,000 | $20.07 | $602,113.20 | -31.7% | - | - | |
| Aug 24, 2020 | APLT Applied Therapeutics, Inc. | Director | Sale+OE | 20,000 | $23.67 | $473,310.36 | -32.9% | - | - | |
| Jun 25, 2020 | APLT Applied Therapeutics, Inc. | Director | Sell | 20,000 | $42.43 | $848,554.66 | -7.3% | - | - | |
| Jun 18, 2020 | APLT Applied Therapeutics, Inc. | Director | Sale+OE | 7,498 | $45.32 | $339,815.74 | -17.9% | - | - | |
| Jun 17, 2020 | APLT Applied Therapeutics, Inc. | Director | Sale+OE | 9,502 | $44.28 | $420,782.74 | -10.4% | - | - |